Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1845 1
1916 1
1921 1
1925 1
1926 1
1931 1
1933 2
1934 1
1938 1
1939 2
1940 1
1941 2
1942 3
1943 1
1945 8
1946 19
1947 8
1948 15
1949 19
1950 11
1951 11
1952 17
1953 16
1954 11
1955 11
1956 20
1957 12
1958 11
1959 9
1960 9
1961 15
1962 13
1963 13
1964 12
1965 12
1966 20
1967 23
1968 28
1969 29
1970 36
1971 47
1972 37
1973 43
1974 47
1975 57
1976 54
1977 62
1978 80
1979 77
1980 105
1981 98
1982 105
1983 102
1984 103
1985 124
1986 132
1987 139
1988 166
1989 205
1990 205
1991 207
1992 242
1993 258
1994 240
1995 271
1996 255
1997 255
1998 260
1999 250
2000 279
2001 299
2002 298
2003 301
2004 339
2005 383
2006 421
2007 432
2008 493
2009 528
2010 548
2011 617
2012 635
2013 620
2014 698
2015 705
2016 719
2017 741
2018 717
2019 778
2020 848
2021 862
2022 849
2023 796
2024 283

Text availability

Article attribute

Article type

Publication date

Search Results

17,210 results

Results by year

Filters applied: . Clear all
Page 1
Manipulating mitochondrial electron flow enhances tumor immunogenicity.
Mangalhara KC, Varanasi SK, Johnson MA, Burns MJ, Rojas GR, Esparza Moltó PB, Sainz AG, Tadepalle N, Abbott KL, Mendiratta G, Chen D, Farsakoglu Y, Kunchok T, Hoffmann FA, Parisi B, Rincon M, Vander Heiden MG, Bosenberg M, Hargreaves DC, Kaech SM, Shadel GS. Mangalhara KC, et al. Among authors: johnson ma. Science. 2023 Sep 22;381(6664):1316-1323. doi: 10.1126/science.abq1053. Epub 2023 Sep 21. Science. 2023. PMID: 37733872
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Bustamante Alvarez J, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L; DeLLphi-301 Investigators. Ahn MJ, et al. Among authors: johnson ml. N Engl J Med. 2023 Nov 30;389(22):2063-2075. doi: 10.1056/NEJMoa2307980. Epub 2023 Oct 20. N Engl J Med. 2023. PMID: 37861218 Clinical Trial.
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy.
Yu HA, Goto Y, Hayashi H, Felip E, Chih-Hsin Yang J, Reck M, Yoh K, Lee SH, Paz-Ares L, Besse B, Bironzo P, Kim DW, Johnson ML, Wu YL, John T, Kao S, Kozuki T, Massarelli E, Patel J, Smit E, Reckamp KL, Dong Q, Shrestha P, Fan PD, Patel P, Sporchia A, Sternberg DW, Sellami D, Jänne PA. Yu HA, et al. Among authors: johnson ml. J Clin Oncol. 2023 Dec 10;41(35):5363-5375. doi: 10.1200/JCO.23.01476. Epub 2023 Sep 10. J Clin Oncol. 2023. PMID: 37689979 Free PMC article. Clinical Trial.
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease.
Sung YJ, Yang C, Norton J, Johnson M, Fagan A, Bateman RJ, Perrin RJ, Morris JC, Farlow MR, Chhatwal JP, Schofield PR, Chui H, Wang F, Novotny B, Eteleeb A, Karch C, Schindler SE, Rhinn H, Johnson ECB, Oh HS, Rutledge JE, Dammer EB, Seyfried NT, Wyss-Coray T, Harari O, Cruchaga C. Sung YJ, et al. Among authors: johnson m. Sci Transl Med. 2023 Jul 5;15(703):eabq5923. doi: 10.1126/scitranslmed.abq5923. Epub 2023 Jul 5. Sci Transl Med. 2023. PMID: 37406134 Free PMC article.
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Guan X, Hu R, Choi Y, Srivats S, Nabet BY, Silva J, McGinnis L, Hendricks R, Nutsch K, Banta KL, Duong E, Dunkle A, Chang PS, Han CJ, Mittman S, Molden N, Daggumati P, Connolly W, Johnson M, Abreu DR, Cho BC, Italiano A, Gil-Bazo I, Felip E, Mellman I, Mariathasan S, Shames DS, Meng R, Chiang EY, Johnston RJ, Patil NS. Guan X, et al. Among authors: johnson m. Nature. 2024 Mar;627(8004):646-655. doi: 10.1038/s41586-024-07121-9. Epub 2024 Feb 28. Nature. 2024. PMID: 38418879
Multigenerational diabetes mellitus.
Thornton JM, Shah NM, Lillycrop KA, Cui W, Johnson MR, Singh N. Thornton JM, et al. Among authors: johnson mr. Front Endocrinol (Lausanne). 2024 Jan 15;14:1245899. doi: 10.3389/fendo.2023.1245899. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38288471 Free PMC article. Review.
Anthracycline Toxicity.
Johnson M, Keyes D. Johnson M, et al. 2024 Jan 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 Jan 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 38261713 Free Books & Documents.
Heart Transplantation-Postoperative Considerations.
Demiralp G, Arrigo RT, Cassara C, Johnson MR. Demiralp G, et al. Among authors: johnson mr. Crit Care Clin. 2024 Jan;40(1):137-157. doi: 10.1016/j.ccc.2023.05.004. Epub 2023 Sep 9. Crit Care Clin. 2024. PMID: 37973350 Review.
Assessing potential of psilocybin for depressive disorders.
Kozak Z, Johnson MW, Aaronson ST. Kozak Z, et al. Among authors: johnson mw. Expert Opin Investig Drugs. 2023 Jul-Dec;32(10):887-900. doi: 10.1080/13543784.2023.2273493. Epub 2023 Nov 6. Expert Opin Investig Drugs. 2023. PMID: 37869790 Review.
17,210 results
You have reached the last available page of results. Please see the User Guide for more information.